Pregnancy in a patient with essential thrombocytosis.
An insurgent case of pregnancy in a patient in whom essential thrombocytosis was diagnosed five years earlier is described. Pregnancy was confirmed and therapy with platelet aggregation inhibitor was introduced. The pregnancy reached full term notwithstanding a positive result of the "Triple Test" during the 15th week of gestation. A histology exam of the placenta revealed an ischemic lesion. We retain that platelet aggregation inhibitor therapy remains an important aid in eliminating the risk of thrombosis determined by the presence of two conditions that are predisposed to these risks, such as pregnancy and essential thrombocytosis.
Rossi
G
G
Department of Infectious Diseases, Ospedale S. Maria Sopra i Ponti, Arezzo, Italy.
Appiano
G
G
Lapini
L
L
Caremani
M
M
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007511:Ischemia / Q000209:etiology; D010920:Placenta / Q000098:blood supply; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011256:Pregnancy Outcome; D013922:Thrombocytosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin